Live Breaking News & Updates on Impact Assessment Model

Stay updated with breaking news from Impact assessment model. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FIRST LICENSED MELATONIN FOR SLEEP DISORDERS IN CHILDREN AND ADOLESCENTS WITH ADHD LAUNCHES IN UK

Swedish Pharmaceutical Company, AGB-Pharma, has recently launched Adaflex, the UK’s first melatonin product for insomnia in children and adolescents aged 6-17 years old with ADHD (where sleep hygiene measures have been insufficient). Melatonin has long been understood as an effective and safe treatment for . ....

United Kingdom , City Of , Fredrik Lindberg , Public Health , Scandj Public Health , Swedish Pharmaceutical Company , Mental Health Services , Products Agency , Adolescent Mental Health Services , Paediatric Psychiatrist , Qualitative Interview Study , Child Psychiatrists , Data Analysis , Impact Assessment Model , Data March , Public Assessment Report , Sleep Disorders , Data Index ,